FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2614121447> ?p ?o ?g. }

• W2614121447 endingPage "1566.e1" @default.
• W2614121447 startingPage "1556" @default.
• W2614121447 abstract "ObjectiveTo report the initial and midterm results of the Bolton Relay Thoracic Stent Graft for the endovascular treatment of thoracic aortic lesions [thoracic endovascular aortic repair (TEVAR)].MethodsThe Bolton Relay Thoracic Aortic Endovascular Pivotal Trial was a prospective, nonrandomized, multicenter, U.S. Investigational Device Exemption study conducted at 27 U.S. investigational sites. One hundred twenty TEVAR subjects were treated with the Relay device between January 2007 and May 2010, with 13 patients enrolled during the continued access phase through September 2012. TEVAR outcomes were compared with a prospectively and retrospectively enrolled surgical cohort consisting of 60 patients enrolled under similar inclusion/exclusion criteria. Follow-up examinations were prescribed at 1 month, 6 months, and yearly thereafter for 5 years. Major adverse events (MAEs) included stroke, paralysis/paraplegia, myocardial infarction, procedural bleeding, respiratory failure, renal failure, wound healing complications, and aneurysm-related mortality.ResultsStent grafts were successfully delivered and deployed in 129 of 133 patients (97.0%). At 30 days, a lower rate of mortality was observed in the TEVAR arm (5.3% vs 10.0%; P = .230), and TEVAR was associated with a significantly lower rate of MAEs (20.3% vs 48.3%; P < .001), primarily driven by a lower frequency of respiratory failure in the cohort (5.5% vs 21.6%; P = .007) and procedural bleeding. Freedom from aneurysm-related mortality through 5 years was similar at 91.3% for the TEVAR cohort and 89.4% for the surgical cohort (P = .406); with 5-year freedom from all-cause mortality at 57.1% and 50.2% (P = .289), respectively. Freedom from MAEs through 5 years was significantly higher in the TEVAR cohort (65.7% vs 44.7%; P = .001). Six TEVAR patients (4.5%) experienced core laboratory-reported type I or III endoleaks, and secondary procedures were performed in 10 patients (7.5%), with seven procedures to correct endoleak and one surgical conversion. Endograft migration occurred in three patients (2.3%) and wireform fractures were assessed in two patients (1.5%). Aneurysm sac size decreased or remained stable in 113 patients (85.0%) over 5-year follow-up. There were no instances of rupture or endograft occlusion. A 38-subject subset treated with the newer Relay Plus Delivery System had a significantly reduced MAE rate (15.8% vs 35.8%; P = .035), and fewer perioperative strokes (2.6% vs 12.6%; P = .108).ConclusionsData from the Relay TEVAR clinical trial demonstrate safety and effectiveness of the Relay device compared with surgical controls, indicating continued device durability with a low rate of device-related complications through 5 years." @default.
• W2614121447 created "2017-05-26" @default.
• W2614121447 creator A5009103078 @default.
• W2614121447 creator A5025639657 @default.
• W2614121447 creator A5069528979 @default.
• W2614121447 creator A5081890576 @default.
• W2614121447 creator A5089306278 @default.
• W2614121447 date "2017-06-01" @default.
• W2614121447 modified "2023-09-26" @default.
• W2614121447 title "Initial and midterm results of the Bolton Relay Thoracic Aortic Endovascular Pivotal Trial" @default.
• W2614121447 cites W198249040 @default.
• W2614121447 cites W2002885791 @default.
• W2614121447 cites W2026673368 @default.
• W2614121447 cites W2028502048 @default.
• W2614121447 cites W2053514845 @default.
• W2614121447 cites W2089291240 @default.
• W2614121447 cites W2114446019 @default.
• W2614121447 cites W2135876063 @default.
• W2614121447 cites W2185839665 @default.
• W2614121447 doi "https://doi.org/10.1016/j.jvs.2016.11.061" @default.
• W2614121447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28527926" @default.
• W2614121447 hasPublicationYear "2017" @default.
• W2614121447 type Work @default.
• W2614121447 sameAs 2614121447 @default.
• W2614121447 citedByCount "29" @default.
• W2614121447 countsByYear W26141214472018 @default.
• W2614121447 countsByYear W26141214472019 @default.
• W2614121447 countsByYear W26141214472020 @default.
• W2614121447 countsByYear W26141214472021 @default.
• W2614121447 countsByYear W26141214472022 @default.
• W2614121447 countsByYear W26141214472023 @default.
• W2614121447 crossrefType "journal-article" @default.
• W2614121447 hasAuthorship W2614121447A5009103078 @default.
• W2614121447 hasAuthorship W2614121447A5025639657 @default.
• W2614121447 hasAuthorship W2614121447A5069528979 @default.
• W2614121447 hasAuthorship W2614121447A5081890576 @default.
• W2614121447 hasAuthorship W2614121447A5089306278 @default.
• W2614121447 hasBestOaLocation W26141214471 @default.
• W2614121447 hasConcept C118552586 @default.
• W2614121447 hasConcept C126322002 @default.
• W2614121447 hasConcept C127413603 @default.
• W2614121447 hasConcept C141071460 @default.
• W2614121447 hasConcept C2776098176 @default.
• W2614121447 hasConcept C2776543907 @default.
• W2614121447 hasConcept C2777323849 @default.
• W2614121447 hasConcept C2777597760 @default.
• W2614121447 hasConcept C2778583881 @default.
• W2614121447 hasConcept C2778620186 @default.
• W2614121447 hasConcept C2779993416 @default.
• W2614121447 hasConcept C2780645631 @default.
• W2614121447 hasConcept C2780775167 @default.
• W2614121447 hasConcept C2780847584 @default.
• W2614121447 hasConcept C500558357 @default.
• W2614121447 hasConcept C535046627 @default.
• W2614121447 hasConcept C71924100 @default.
• W2614121447 hasConcept C72563966 @default.
• W2614121447 hasConcept C78519656 @default.
• W2614121447 hasConceptScore W2614121447C118552586 @default.
• W2614121447 hasConceptScore W2614121447C126322002 @default.
• W2614121447 hasConceptScore W2614121447C127413603 @default.
• W2614121447 hasConceptScore W2614121447C141071460 @default.
• W2614121447 hasConceptScore W2614121447C2776098176 @default.
• W2614121447 hasConceptScore W2614121447C2776543907 @default.
• W2614121447 hasConceptScore W2614121447C2777323849 @default.
• W2614121447 hasConceptScore W2614121447C2777597760 @default.
• W2614121447 hasConceptScore W2614121447C2778583881 @default.
• W2614121447 hasConceptScore W2614121447C2778620186 @default.
• W2614121447 hasConceptScore W2614121447C2779993416 @default.
• W2614121447 hasConceptScore W2614121447C2780645631 @default.
• W2614121447 hasConceptScore W2614121447C2780775167 @default.
• W2614121447 hasConceptScore W2614121447C2780847584 @default.
• W2614121447 hasConceptScore W2614121447C500558357 @default.
• W2614121447 hasConceptScore W2614121447C535046627 @default.
• W2614121447 hasConceptScore W2614121447C71924100 @default.
• W2614121447 hasConceptScore W2614121447C72563966 @default.
• W2614121447 hasConceptScore W2614121447C78519656 @default.
• W2614121447 hasIssue "6" @default.
• W2614121447 hasLocation W26141214471 @default.
• W2614121447 hasLocation W26141214472 @default.
• W2614121447 hasOpenAccess W2614121447 @default.
• W2614121447 hasPrimaryLocation W26141214471 @default.
• W2614121447 hasRelatedWork W1766343418 @default.
• W2614121447 hasRelatedWork W1965696191 @default.
• W2614121447 hasRelatedWork W2002398460 @default.
• W2614121447 hasRelatedWork W2013767293 @default.
• W2614121447 hasRelatedWork W2045966422 @default.
• W2614121447 hasRelatedWork W2112134339 @default.
• W2614121447 hasRelatedWork W2130835599 @default.
• W2614121447 hasRelatedWork W2287051346 @default.
• W2614121447 hasRelatedWork W2394922615 @default.
• W2614121447 hasRelatedWork W4377262004 @default.
• W2614121447 hasVolume "65" @default.
• W2614121447 isParatext "false" @default.
• W2614121447 isRetracted "false" @default.
• W2614121447 magId "2614121447" @default.
• W2614121447 workType "article" @default.